Congratulations to Alice REFEYTON, Marija Vlaski-Lafarge and the EFS research team in Bordeaux directed by Zoran Ivanovic, part of MRGM : Maladies Rares Génétiques et Métabolisme laboratory Inserm U1211. An original alternative pathway for OXPHOS fueling is discovered in this work with implications for human stem cells therapy. Great collaboration with Milos Filipovic team.

Département Sciences Biologiques et Médicales Université de Bordeaux CELLOMET